Form 4: Simulations Plus Director Reports Future Stock Sale
Insider Transaction Report
Simulations Plus Director Lisa LaVange filed a Form 4 reporting a future sale of 867 shares of common stock at $14.10 per share under a Rule 10b5-1 plan.
Summary
- Lisa LaVange, a Director of Simulations Plus, Inc. (SLP), reported a planned disposition of common stock.
- The transaction involves the sale of 867 shares of common stock.
- The shares are scheduled to be sold at a price of $14.10 per share.
- The sale is set to occur on September 2, 2025.
- This transaction is being executed automatically pursuant to a pre-arranged Rule 10b5-1 plan.
- Following this planned transaction, Ms. LaVange will beneficially own 9,063 shares directly.
Sentiment
Score: 5
Explanation: The transaction is a routine, pre-planned insider sale under a 10b5-1 plan, which is generally considered neutral. The small number of shares involved further limits its market impact.
Positives
- The sale is being conducted under a Rule 10b5-1 plan, indicating it was pre-scheduled and not based on new, non-public information, which enhances transparency and mitigates concerns of opportunistic insider trading.
- The filing of the Form 4 prior to the transaction date provides early disclosure of the planned sale.
Negatives
- The planned sale, while pre-arranged, will result in a reduction of insider ownership, which can sometimes be perceived as a minor negative signal by the market, even if routine.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction, as it is solely an insider transaction report.
Industry Context
This insider transaction is specific to Simulations Plus, Inc. and does not provide broader insights into industry trends or competitive landscape.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Policy Adherence | The planned sale of shares is executed under a Rule 10b5-1 plan, demonstrating adherence to insider trading policies and pre-scheduled transactions to avoid accusations of trading on material non-public information. | 09/02/2025 | Mitigates concerns of opportunistic insider trading by ensuring transactions are pre-arranged and not based on material non-public information, thereby upholding corporate governance standards. |
Stakeholder Impact
- Shareholders: The planned sale represents a minor reduction in insider ownership, but its pre-planned nature under a 10b5-1 plan typically minimizes any negative signaling effect.
Key Dates
| Date | Description |
|---|---|
| 09/02/2025 | Planned transaction date for the sale of 867 shares of common stock. |
| 09/04/2025 | Date the Form 4 filing was signed and submitted. |
Recommendation
holdThe reported transaction is a pre-scheduled sale by a director under a Rule 10b5-1 plan. This is a common practice for managing personal stock holdings and does not typically signal a change in the company's fundamental outlook. The relatively small number of shares sold (867 shares, valued at approximately $12,224.70) and the pre-planned nature suggest it is not a material event warranting a change in investment posture.
Keywords
Simulations Plus, SLP, insider trading, Form 4, stock sale, director, Lisa LaVange, 10b5-1 plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.